Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Electromagnetic field versus diclofenac drugs on primary dysmenorrhea: Arandomized controlled trial in the Egyptian women
Background: Primary dysmenorrhea is one of the most common complaints of women and is also the most common gynecological problem worldwide. These cramps are recurrent and 90% adolescent girls and about 50% women suffer from it. Purpose of the study: to determine which is more effective in alleviating primary dysmenorrhea; pulsed electromagnetic field or diclofenac drugs. Methodology: The study was a randomized, double-blinded trial, fifty adult females participated in this study, were divided randomly into two groups equal in numbers: group (A) received pulsed electromagnetic field applied on pelvic region, 3 times per week for 3 months, 20 minutes per day and group (B) received diclofenac tablets, 50 mg only with onset of menstrual pain. All participants in both groups (A and B) were assessed pre- and post-treatment through measuring progesterone level in the blood, assessment of pain using visual analogue scale and physical as well as psychological symptoms by using menstrual symptom questionnaire.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Pulsed electromagnetic field | Active Comparator | magnetic therapy device which generate frequency from 5-100 Hz and intensity from 1 to 60 Gauss. Group (A) received 20 min 3 times per week for three month with strength 60 gauss and frequency 50 Hz |
|
| diclofenac tablets | Experimental | (50 mg) few hours at the onset of menstruation for 3 months |
|
| Visual analogue scale | Other | was used to determine the pain intensity level. Pain assessed before and after treatment procedure (3 month) |
|
| Progesterone blood level | Other | Sample of blood was taken to detect the level of progesterone. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Pulsed electromagnetic field | Device | EASY Qs portable (by ASA, Italy) |
|
| Measure | Description | Time Frame |
|---|---|---|
| Visual analogue scale | was used to determine the pain intensity level. Pain assessed before and after treatment procedure (3 month); in both groups (A and B) by (16), it is a graphic rating scale with numerical values placed equidistantly along the line. The descriptors and numbers help the subject to place her estimate on line in which (0) mean no pain, (1) equal mild pain, (2) equal moderate pain, (3) mean severe pain and (4) mean unbearable pain. | three months |
| Measure | Description | Time Frame |
|---|---|---|
| Progesterone blood level | Sample of blood was taken to detect the level of progesterone. | three months |
| Menstrual symptom questionnaire | to assess symptoms of dysmenorrhea |
Not provided
Inclusion Criteria:
-regular menstrual cycle 21-35 days lasting 3-7 days
Exclusion Criteria:
females
Not provided
Not provided
Electromagnetic field versus diclofenac drugs on primary dysmenorrhea: Arandomized controlled trial in the Egyptian women
three months
the protocol of study, for 3 months
Not provided
Not provided
| ID | Term |
|---|---|
| D004412 | Dysmenorrhea |
| ID | Term |
|---|---|
| D008599 | Menstruation Disturbances |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D017699 | Pelvic Pain |
Not provided
Not provided
| ID | Term |
|---|---|
| D004008 | Diclofenac |
| D010147 | Pain Measurement |
| ID | Term |
|---|---|
| D010648 | Phenylacetates |
| D000146 | Acids, Carbocyclic |
| D002264 | Carboxylic Acids |
| D009930 | Organic Chemicals |
Not provided
Not provided
Not provided
Not provided
Not provided
(Participant, Outcomes Assessor)
| Menstrual symptom questionnaire | Other | to assess symptoms of dysmenorrhea. |
|
| diclofenac tablets | Drug | drugs |
|
| Visual analogue scale | Diagnostic Test | a graphic rating scale |
|
| Progesterone blood level | Diagnostic Test | blood test |
|
| Menstrual symptom questionnaire | Diagnostic Test | questionnaire |
|
| three months |
| D010146 | Pain |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D009460 |
| Neurologic Examination |
| D010808 | Physical Examination |
| D019937 | Diagnostic Techniques and Procedures |
| D003933 | Diagnosis |